Farida Merah is the leader of in vitro biocompatibility at Charles River Canada, where she currently builds up in vitro biocompatibility for the safety assessment of medical devices. She has extensive experience in in vitro and in vivo genetic toxicology and infection studies and has conducted over 450 safety assessment studies of pharmaceuticals, chemicals, and medical devices. Farida has also directed the validation of assays and computerized systems. She previously worked at ITR Laboratories building up their genetic toxicology department.
Farida holds a master’s degree in microbiology and biochemistry. She has broad knowledge with ICH, OECD, ISO, ASTM, GLP, GMP, and GCP guidelines, and has authored/coauthored several scientific posters.